Sheets Smith Wealth Management Dexcom Inc Transaction History

Sheets Smith Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$114.22 - $140.1 $371,329 - $455,465	3,251 New	3,251 $450,000
Q2 2023 Aug 09, 2023	BUY	$112.47 - $130.98 $385,884 - $449,392	3,431 New	3,431 $440,000
Q4 2020 Jan 13, 2021	SELL	$78.0 - $104.5 $78,468 - $105,127	-1,006 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$95.51 - $112.95 $96,083 - $113,627	1,006 New	1,006 $415,000
Q2 2020 Jul 17, 2020	SELL	$62.68 - $105.34 $137,833 - $231,642	-2,199 Closed	0 $0
Q1 2020 Apr 28, 2020	BUY	$47.79 - $75.63 $105,090 - $166,310	2,199 New	2,199 $592,000

1,112

365M

4.1M

3.65M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $25.4B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Sheets Smith Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Sheets Smith Wealth Management with notifications on news.